ROSEMONT, Ill, Oct. 24, 2018 /PRNewswire/ -- The American Academy of Orthopaedic Surgeons (AAOS) announced the launch of its Shoulder and Elbow Registry (SER) to begin collecting data on total shoulder and elbow procedures in the United States. At launch, the SER will collect total shoulder arthroplasty procedures data. In 2019, the registry also will have the capability to capture rotator
KFAR SABA, Israel and MILAN, Oct. 25, 2018 /PRNewswire/ -- CartiHeal, developer of the proprietary Agili-C implant for the treatment of joint surface lesions, and the Principal Investigator Professor Elizaveta Kon, MD, PhD of Humanitas Orthopedic Center of Milan, announced today the successful enrollment and surgery of the 100th patient in the Agili-C IDE pivotal study. "I'm excited to operate on the 100th patient
SAN DIEGO, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Samumed announced today top-line data from its phase 2b trial of SM04690 in knee osteoarthritis (OA). Results showed that treatment with a single intra-articular injection of SM04690 demonstrated significant improvements in pain, function and patient global scores in two separate doses. Further details can be found here. Samumed’s
October 25, 2018 DURHAM, N.C.--(BUSINESS WIRE)--Bioventus, a global leader in orthobiologic solutions, today announced the appointment of Susan M. Stalnecker, former Vice President and Treasurer, E.I. du Pont de Nemours and Company, to the company’s Board of Managers, replacing Michael Minogue. “Susan is joining the Bioventus Board at an exciting time as we accelerate the growth of our
WAYNE, Pa., Oct. 25, 2018 /PRNewswire/ -- Camber Spine today announced reaching the $1 million milestone with their recently launched SPIRA™-C in less than 6 months. "The remarkable success and the early adoption of this revolutionary technology by so many surgeon users has attributed to this milestone," commented CEO, Daniel Pontecorvo. "Camber Spine is now following through on its promise to be
CARLSBAD, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (TSXV:ASG) ("Aurora Spine" or the "Company") announced today the grant by the European Patent Office (the “EPO”) of Aurora’s first European patent related to the ZIP®, minimally invasive spinal implant. The patent is titled “Dynamic and Non-Dynamic Interspinous Fusion Implant and Bone Growth Stimulation
October 25, 2018 HOUSTON--(BUSINESS WIRE)--SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc nucleus using human dermal fibroblasts (HDFs), today announced 12-month endpoint data from its Phase 1/Phase 2 clinical trial for treatment of degenerative disc disease (DDD). The analysis showed that patients who received intradiscal injections of the HDF
October 23, 2018 HUNTLEY, Ill.--(BUSINESS WIRE)--Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that the company recognized an EBITDA growth rate of 124% in the third quarter of 2018 over the third quarter of 2017. This was driven by a sales
October 24, 2018 BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology, today reported financial results for the third quarter ended September 30, 2018, and provided an update on its business progress in the period. “Anika delivered solid financial results
October 24, 2018 BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (NASDAQ: ANIK) (“Anika” or the “Company”), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology, announced that, effective immediately, Anika’s Board of Directors has appointed Susan Vogt as an independent director. Ms. Vogt most recently served as Chief Executive
